ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer

PURPOSE: ErbB2 signaling appears to be increased and may enhance AR activity in a subset of CRPC, but agents targeting ErbB2 have not been effective. This study was undertaken to assess ErbB2 activity in abiraterone-resistant prostate cancer (PCa), and determine whether it may contribute to androgen...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Cancer Res
मुख्य लेखकों: Gao, Shuai, Ye, Huihui, Gerrin, Sean, Wang, Hongyun, Sharma, Ankur, Chen, Sen, Patnaik, Akash, Sowalsky, Adam G., Voznesensky, Olga, Han, Wanting, Yu, Ziyang, Mostaghel, Elahe A., Nelson, Peter S., Taplin, Mary-Ellen, Balk, Steven P., Cai, Changmeng
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2016
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4947432/
https://ncbi.nlm.nih.gov/pubmed/26936914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2309
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन